Antley Dayton L, Nelson Leigh Anne, Kriz Carrie R, Iuppa Courtney A, Lang Shelby E, Gramlich Nicole A, Elliott Ellie S R, Sommi Roger W
PGY2 Psychiatric Pharmacy Resident, Center for Behavioral Medicine, Kansas City, Missouri.
Professor of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri,
Ment Health Clin. 2023 Jan 5;12(6):350-355. doi: 10.9740/mhc.2022.12.350. eCollection 2022 Dec.
To describe the publication rates and characteristics of PGY2 psychiatric pharmacy residency projects presented as a poster presentation at the annual meetings of the College of Psychiatric and Neurologic Pharmacists (CPNP) from 2002 to 2018. (As of 2022 the organization is under the name, American Association of Psychiatric Pharmacists.).
CPNP abstracts from even years were strategically searched in PubMed, Ovid MEDLINE, and Google Scholar. If a publication was identified, additional data were collected for characterization, including study information, journal information, author information, institutional affiliation, publication year, and time to publication.
A total of 348 abstracts were evaluated. Publication in a journal was achieved for 60 projects (17.2%), with publication rates decreasing from 2012 to 2018. The mean time to publication was 17.3 months after completion of the residency, with most projects published at 8 months. More than half (51.7%) of these projects were published in a psychiatric pharmacy journal affiliated with CPNP. Study designs were predominantly retrospective, observational, cohort studies with a focus on evaluation of a drug therapy outcome. The PGY2 resident was the first author in 90% of the publications. Forty percent included other health care professionals outside of pharmacy as a coauthor. PGY2 residencies affiliated with academic institutions had overall higher publications rates.
Publication rates for PGY2 psychiatric pharmacy residency projects are low and are decreasing over time despite an increasing number of PGY2 psychiatric pharmacy residency programs. This publication rate is lower than that reported in the literature for PGY2 critical care residency programs. The downward trend of publication rates for PGY2 psychiatric pharmacy residency projects is concerning.
描述2002年至2018年期间在精神科和神经科药剂师学会(CPNP)年会上以海报形式展示的PGY2精神科药学住院医师培训项目的发表率及特征。(截至2022年,该组织名称为美国精神科药剂师协会。)
在PubMed、Ovid MEDLINE和谷歌学术中对偶数年份的CPNP摘要进行策略性检索。若确定有发表文章,则收集更多用于特征描述的数据,包括研究信息、期刊信息、作者信息、机构隶属关系、发表年份和发表时间。
共评估了348篇摘要。60个项目(17.2%)在期刊上发表,发表率从2012年至2018年呈下降趋势。发表的平均时间为住院医师培训结束后17.3个月,大多数项目在8个月时发表。其中超过一半(51.7%)的项目发表在与CPNP相关的精神科药学杂志上。研究设计主要为回顾性、观察性队列研究,重点是评估药物治疗结果。90%的发表文章中PGY2住院医师为第一作者。40%的文章将药学以外的其他医疗保健专业人员列为共同作者。与学术机构相关的PGY2住院医师培训项目总体发表率更高。
尽管PGY2精神科药学住院医师培训项目数量不断增加,但PGY2精神科药学住院医师培训项目的发表率较低且呈下降趋势。这一发表率低于文献中报道的PGY2重症监护住院医师培训项目的发表率。PGY2精神科药学住院医师培训项目发表率的下降趋势令人担忧。